A platform for analyzing immunology data
Official title: THE IMMUNOLOGY DATABASE AND ANALYSIS PORTAL (IMMPORT)
NIH-10688682 · Data updated 2026-11-12
This study is all about making it easier for researchers to access and share important information about the immune system, so they can better understand and improve treatments for diseases.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Project start | September 30, 2022 |
| Project end | September 29, 2027 |
| Funding year | 2022 |
| Award (this year) | $230,855 |
| NIH project number | 316201200036W-0-759302200001-2 |
| Project ID | NIH-10688682 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include individuals involved in biodefense immunology research or those who require access to comprehensive immunological data.
✕Less likely to help
Patients not involved in immunology research or those outside the biodefense context may not receive direct benefits from this research.
What this research studies
This research focuses on enhancing a bioinformatics platform called ImmPort, which supports biodefense immunology research. It aims to improve methods for collecting, storing, and sharing clinical data, making it easier for researchers to access and analyze important immunological information. The project will also develop new tools for data integration and retrieval, ensuring that users can efficiently work with the data they need. By providing technical support and optimizing user experience, this initiative seeks to advance the field of immunology.
Why it matters
Potential benefit: If successful, this research could significantly improve the accessibility and usability of immunology data for researchers, leading to better insights and advancements in immunological treatments.
How similar studies have gone: Previous research has shown success in developing bioinformatics platforms for data analysis, indicating that this approach has potential for impactful results.
Where this research is happening
Dulles, United States
Researchers
- Principal investigator: Butte, Atul
- Study coordinator: Butte, Atul
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.